Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 13

Zeitschriftenartikel

Müller-Peltzer, K.; Figueiredo, G. Negrao de; Fischereder, M.; Habicht, A.; Ruebenthaler, J. und Clevert, D.-A. (2018): Contrast-enhanced ultrasound (CEUS) as a new technique to characterize suspected renal transplant malignancies in renal transplant patients in comparison to standard imaging modalities. In: Clinical Hemorheology and Microcirculation, Bd. 69, Nr. 1-2: S. 69-75

Müller-Peltzer, K.; Figueiredo, G. Negrao de; Fischereder, M.; Habicht, A.; Ruebenthaler, J. und Clevert, D-A (2018): Vascular rejection in renal transplant: Diagnostic value of contrast-enhanced ultrasound (CEUS) compared to biopsy. In: Clinical Hemorheology and Microcirculation, Bd. 69, Nr. 1-2: S. 77-82

Müller-Peltzer, K.; Rübenthaler, J.; Fischereder, M.; Habicht, A.; Reiser, M. und Clevert, Dirk-André (2017): The diagnostic value of contrast-enhanced ultrasound (CEUS) as a new technique for imaging of vascular complications in renal transplants compared to standard imaging modalities. In: Clinical Hemorheology and Microcirculation, Bd. 67, Nr. 43193: S. 407-413

Hoppe, J.; Holderied, A.; Schäfer, H.; Schönermarck, U.; Anders, H. J. und Fischereder, M. (2017): Drug-induced cytochrome-p450 induction as therapy for calcineurin inhibitor intoxication. In: Transplant international, Bd. 30: S. 33

Fischereder, M.; Habicht, A.; Stangl, M. und Müller, S. (2017): Expression of PD-L1 in Squamous Carcinoma of the Skin of Renal Transplant Recipients. In: Transplant international, Bd. 30: S. 30

Fischereder, M.; Friedrich, S.; Klingmüller, U.; Kauke, T.; Breidenbach, T.; Bösebeck, D.; Angelika, E.; Cohen, C.; Banas, B.; Guba, M.; Stangl, M.; Krämer, B.; Hugo, C.; Lopau, K.; Stadtler, M. und Mone, T. (2017): A Mutation of the Erythropoietin Receptor Correlates with Improved Function of Deceased-Donor Renal Transplants. In: American Journal of Transplantation, Bd. 17: S. 360

Naik, M.; Arns, W.; Basic, E.; Budde, K.; Diekmann, F.; Fischereder, M.; Gossmann, J.; Gwinner, W.; Heller, K.; Heyne, N.; Jürgensen, J. S.; Morath, C. und Riester, U. (2017): Patient And Graft Survival In Patients With Previous Malignancies After Conversion MTOR Inhibitor Sirolimus In A Large German Cohort. In: Transplant international, Bd. 30: S. 33-34

Schönermarck, U.; Dengler, C.; Gmeinwieser, A.; Praun, S.; Schelling, Gustav; Fischereder, M.; Boulesteix, Anne-Laure und Dolch, M. E. (2016): Exhaled breath volatile organic and inorganic compound composition in end-stage renal disease. In: Clinical Nephrology, Bd. 86, Nr. 9: S. 132-140

Scherbaum, C. R. und Fischereder, M. (2016): Diabetes und Dialyse. In: Diabetologe, Bd. 12, Nr. 3: S. 209-217

Stumpp, J.; Rau, S.; Werner, J.; Meiser, B.; Andrassy, J.; Fischereder, M.; Stangl, M. und Habicht, A. (2016): INDUCTION THERAPY IN LOW-RISK RENAL ALLOGRAFT RECIPIENTS - CAN WE SPARE IT TO AVOID INFECTIOUS COMPLICATIONS? In: Transplant international, Bd. 29: S. 27

Sauter, M.; Sigl, J.; Schotten, Klaus-Jürgen; Kreuzer, L.; Gunthner-Biller, M. und Fischereder, M. (2015): Use of oestrogen-containing medication is not associated with renal angiomyolipoma in tuberous sclerosis: findings from a survey. In: International Urology and Nephrology, Bd. 47, Nr. 4: S. 707-708

Andrassy, J.; Hoffmann, V. S.; Rentsch, M.; Stangl, M.; Habicht, A.; Meiser, B.; Fischereder, M.; Jauch, Karl-Walter und Guba, M. (2012): Is Cytomegalovirus Prophylaxis Dispensable in Patients Receiving an mTOR Inhibitor-Based Immunosuppression? A Systematic Review and Meta-Analysis. In: Transplantation, Bd. 94, Nr. 12: S. 1208-1217

Hoffmann, U.; Banas, B.; Fischereder, M. und Kramer, B. K. (2004): N-acetylcysteine in the prevention of radiocontrast-induced nephropathy: Clinical trials and end points. In: Kidney & Blood Pressure Research, Nr. 3: S. 161-166 [PDF, 99kB]

Diese Liste wurde am Sun Mar 24 00:23:31 2024 CET erstellt.